Location History:
- Loma Linda, CA (US) (2010 - 2014)
- Redlands, CA (US) (1989 - 2020)
Company Filing History:
9 out of 233 
4 out of 896 
2 out of 3 
Years Active: 1989-2025
Title: David J Baylink: Innovator in Dendritic Cell Research
Introduction
David J Baylink is a prominent inventor based in Redlands, California, recognized for his significant contributions to the field of biotechnology and stem cell research. With an impressive portfolio of 22 patents, he has been at the forefront of developing innovative methods for treating inflammation-related conditions and advancing stem cell technology.
Latest Patents
Among his latest patents, Baylink has designed a method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells, thereby offering new avenues for treating gut inflammation. His technology involves gene-modified, lymphoid-tissue-homing dendritic cells that express a 1-alpha-hydroxylase gene and a retinaldehyde dehydrogenase 2 gene. These genes are crucial for generating functional enzymes that play significant roles in the immune response.
Another noteworthy patent discusses vectors and methods for the efficient generation of integration/transgene-free induced pluripotent stem cells from peripheral blood cells. This innovative method outlines the application of a vector backbone along with transcription and reprogramming factor genes, which are critical in creating induced pluripotent stem cells free from genetic integration. This advancement stands to revolutionize regenerative medicine by enhancing the efficiency and safety of stem cell generation.
Career Highlights
Throughout his career, David Baylink has collaborated with esteemed organizations, including Loma Linda University, where he has been involved in groundbreaking research and development in the biomedical field. His work has enabled significant advancements that could lead to improved treatment options for patients suffering from various inflammatory conditions.
Collaborations
Baylink has worked alongside notable colleagues, including Kin-Hing William Lau and Subburaman Mohan, who share his passion for innovation in medical research. Together, they have contributed significantly to the understanding and application of dendritic cell technologies and stem cell therapeutics.
Conclusion
David J Baylink continues to push the boundaries of scientific innovation, driven by his commitment to improving human health through biotechnology. His extensive patent portfolio not only reflects his creativity and expertise but also underscores the potential impact of his work on medical treatments and therapies in the future.